Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetanus revaccination in patients with myasthenia gravis
2014-004344-35Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tetanus toxoid in myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS), sponsored by Leiden University Medical Center. Primary endpoint: Change in tetanus-specific serum IgG titer. Started Feb 2015; status: completed.
02
Drugs
tetanus toxoid
03
Conditions
myasthenia gravis (MG)Lambert-Eaton myasthenic syndrome (LEMS)
Beyond the preview
Go deeper on 2014-004344-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004344-35.